Recent advances in CAR-NK cell therapy could revolutionze cancer treatment
Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained...
Zoldonrasib Nets Breakthrough Therapy Designation in KRAS G12D–Mutated NSCLC
The FDA has granted breakthrough therapy designation to zoldonrasib (RMC-9805-001) for the treatment of adult patients with KRAS G12D-mutated locally advanced or metastatic...
Breakthrough treatment for advanced prostate cancer could eliminate severe side effects
Researchers at Case Western Reserve University have developed a treatment for advanced...
Sevabertinib Earns Breakthrough Therapy Designation for HER2+ NSCLC in US/China
Sevabertinib (Hyrnuo) has earned breakthrough therapy designation from the FDA and China’s Center for Drug Evaluation (CDE) for the first-line treatment of patients...
Aurum Capital Launches “Member-Protected Medical Innovation Initiative” to Drive Future Healthcare...
New York, United States,...
FDA Grants Breakthrough Therapy Designation to Alixorexton for the Treatment of...
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Alkermes’ alixorexton for the treatment of narcolepsy type 1 (NT1)....
Bayer receives Breakthrough Therapy Designation in the U.S. and China for...
Berlin, January 6, 2026...
FDA Grants Breakthrough Therapy Designation to Alixorexton for Narcolepsy Type 1
The US Food & Drug Administration (FDA) granted a Breakthrough Therapy Designation to alixorexton for the treatment of narcolepsy type 1, announced by...
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis...
The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate privosegtor (formerly known as OCS-05) for the treatment...
New breakthrough could modernize treatment for glioblastoma
Researchers at the UNC School of Medicine and the UNC Eshelman School of...